mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-10 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-09 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-09 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-09 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |